Analyst Price Target is C$0.40
▲ +110.53% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for MediPharm Labs in the last 3 months. The average price target is C$0.40, with a high forecast of C$0.50 and a low forecast of C$0.35. The average price target represents a 110.53% upside from the last price of C$0.19.
Current Consensus is
The current consensus among 3 contributing investment analysts is to hold stock in MediPharm Labs.
MediPharm Labs Corp., together with its subsidiaries, produces and sells pharmaceutical-grade cannabis oil and concentrates, and advance derivative products in Canada and Australia. It formulates, processes, packages, and distributes cannabis extracts and cannabinoid-based products. The company was founded in 2015 and is headquartered in Barrie, Canada.